We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Metabolic Dysfunction-Associated Steatotic Liver Disease Induced by Microplastics: An Endpoint in the Liver–Eye Axis
AI summary Read the abstract
This review explores the connection between microplastic exposure and liver disease through the lens of the liver-eye axis, a physiological link between ocular and hepatic health. Researchers discuss how microplastics can enter the body through the eyes and respiratory tract, accumulate in the liver, and potentially contribute to chronic liver conditions through oxidative damage. The study highlights the need for further research into whether microplastic buildup in the liver is a cause or consequence of liver disease.
There is a significant, rather than just anecdotal, connection between the liver and the eyes. This connection is evident in noticeable cases such as jaundice, where the sclera has a yellow tint. But this can be seen through even more subtle indicators, such as molecules known as hepatokines. This relationship is not merely anecdotal; in some studies, it is referred to as the "liver-eye axis". Ubiquitous environmental contaminants, such as microplastics (MPs), can enter the bloodstream and human body through the conjunctival sac, nasolacrimal duct, and upper respiratory tract mucosa. Once absorbed, these substances can accumulate in various organs and cause harm. Toxic substances from the surface of the eye can lead to local oxidative damage by inducing apoptosis in corneal and conjunctival cells, and irregularly shaped microparticles can exacerbate this effect. Even other toxicants from the ocular surface may be absorbed into the bloodstream and distributed throughout the body. Environmental toxicology presents a challenge because many pollutants can enter the body through the same ocular route as that used by certain medications. Previous research has indicated that the accumulation of MPs may play a major role in the development of chronic liver disease in humans. It is crucial to investigate whether the buildup of MPs in the liver is a potential cause of fibrosis, or simply a consequence of conditions such as cirrhosis and portal hypertension.
More Papers Like This
Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction
AI summary Read the abstract
This review examines emerging evidence linking micro- and nanoplastic exposure to liver disease, including metabolic dysfunction-associated liver disease, cirrhosis, and liver cancer. Researchers found that these particles may contribute to liver damage through oxidative stress, inflammation, and disruption of metabolic pathways. The study highlights the need for further research into how environmental plastic contamination may be influencing the rising rates of liver disease worldwide.
Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health
AI summary Read the abstract
This review examined emerging evidence linking microplastic exposure to the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). The authors found that microplastics detected in liver tissue can exacerbate hepatic inflammation, lipid accumulation, and oxidative stress through multiple mechanisms, adding a novel environmental risk factor to MASLD pathogenesis.
Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions
AI summary Read the abstract
This review summarizes what scientists know about how micro- and nanoplastics affect the liver, which is one of the first organs exposed because it processes everything absorbed from the gut. The particles trigger oxidative stress, disrupt energy metabolism, cause cell death, and promote inflammation, and may contribute to conditions like fatty liver disease and liver fibrosis. The paper also highlights how plastics can disturb the gut microbiome, which communicates with the liver through the gut-liver axis and may amplify liver damage.
Environmental microplastics and liver health: Brief review on human exposure and accumulation, hepatotoxicity mechanism, and intervention strategies
AI summary Read the abstract
This review links human exposure to microplastics, their accumulation in the liver and proposed mechanisms of liver toxicity, including oxidative stress, inflammation and cell death. Most of the evidence comes from cell, animal and organoid studies. It also discusses candidate interventions that are still at the research stage.
Microplastic-mediated new mechanism of liver damage: From the perspective of the gut-liver axis
AI summary Read the abstract
This review describes how microplastics can damage the liver through the gut-liver axis: they first disrupt the gut's protective barrier and beneficial bacteria, allowing harmful substances to leak through the weakened intestinal wall into the bloodstream and travel to the liver. Once there, these substances cause inflammation, metabolic problems, and oxidative stress, offering a new explanation for how microplastic exposure could lead to liver disease.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.